Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test Combined Screening Reflex to NIPS- AutoDELFIA (Astraia) is 14 days.

What are the prerequisites for the test Combined Screening Reflex to NIPS- AutoDELFIA (Astraia)

  • Maternal age must be at least 18 years old
  • Pregnancy must be between 10 weeks and 13 weeks + 6 days
  • Fetal crown-rump length must be between 45mm and 84mm
  • Patient must have a singleton pregnancy
  • Patient must have no known fetal anomalies
  • Patient must not have a history of chromosomal abnormalities in previous pregnancies

What are the measure values for the test Combined Screening Reflex to NIPS- AutoDELFIA (Astraia)

  • Trisomy 21 risk: < 1:270
  • Trisomy 18 risk: < 1:100
  • Trisomy 13 risk: < 1:100
  • Monosomy X risk: < 1:100

What does this test Combined Screening Reflex to NIPS- AutoDELFIA (Astraia) identify?

Combined Screening Reflex to NIPS- AutoDELFIA (Astraia) Test

The Combined Screening Reflex to NIPS- AutoDELFIA (Astraia) test is used to identify the risk of certain chromosomal abnormalities in a developing fetus. This test combines non-invasive prenatal screening (NIPS) with the AutoDELFIA method to provide more accurate results.

The test can help identify conditions such as Down syndrome (trisomy 21), trisomy 18, and trisomy 13. It can also detect sex chromosome abnormalities and certain microdeletions.

By combining NIPS with AutoDELFIA, this test offers improved sensitivity and specificity compared to traditional screening methods. It can help healthcare providers and expectant parents make more informed decisions about prenatal care and potential interventions.

Why is this test Combined Screening Reflex to NIPS- AutoDELFIA (Astraia) taken?

Combined Screening Reflex to NIPS- AutoDELFIA (Astraia)

This test is taken to screen for certain chromosomal abnormalities in a developing fetus. It combines two screening tests: the first trimester combined screening test and non-invasive prenatal screening (NIPS). The first trimester combined screening test involves a blood test and an ultrasound to assess the risk of Down syndrome and other chromosomal abnormalities. NIPS, on the other hand, is a blood test that analyzes fetal DNA in the mother's blood to detect chromosomal abnormalities such as trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), and trisomy 13 (Patau syndrome).

By combining these two screening tests, healthcare providers can provide more accurate and comprehensive information about the risk of chromosomal abnormalities in the fetus. This information can help expectant parents make informed decisions about their pregnancy and prepare for any potential challenges that may arise. The test results are typically analyzed using the AutoDELFIA system, which is a highly sensitive and accurate method for detecting chromosomal abnormalities.

No FAQs available.

Customer Google Rating